Great Novel Therapeutics Biotech & Medicals (ROCO:7427) YoY Rev. per Sh. Growth : 0.00% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Great Novel Therapeutics Biotech & Medicals YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Great Novel Therapeutics Biotech & Medicals's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2023 was 0.00%.

Great Novel Therapeutics Biotech & Medicals's Revenue per Share for the six months ended in Dec. 2023 was NT$0.00.

Great Novel Therapeutics Biotech & Medicals YoY Rev. per Sh. Growth Historical Data

The historical data trend for Great Novel Therapeutics Biotech & Medicals's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Great Novel Therapeutics Biotech & Medicals YoY Rev. per Sh. Growth Chart

Great Novel Therapeutics Biotech & Medicals Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY Rev. per Sh. Growth

Get a 7-Day Free Trial

-97.27

-100.00

-20.00

545.00

Great Novel Therapeutics Biotech & Medicals Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
YoY Rev. per Sh. Growth	Get a 7-Day Free Trial					-	76.92	-100.00	482.61	-

Great Novel Therapeutics Biotech & Medicals YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Great Novel Therapeutics Biotech & Medicals's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY Rev. per Sh. Growth (A: Dec. 2023 )
=	(Revenue per Share (A: Dec. 2023 )	-	Revenue per Share (A: Dec. 2022 ))	/	\| Revenue per Share (A: Dec. 2022 ) \|
=	(0.129	-	0.02)	/	\| 0.02 \|
=	545.00 %

Great Novel Therapeutics Biotech & Medicals's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2023 is calculated as:

	YoY Rev. per Sh. Growth (Q: Dec. 2023 )
=	(Revenue per Share (Q: Dec. 2023 )	-	Revenue per Share (Q: Dec. 2022 ))	/	\| Revenue per Share (Q: Dec. 2022 )) \|
=	(0.002	-	0)	/	\| 0 \|
=	N/A %

Great Novel Therapeutics Biotech & Medicals YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Great Novel Therapeutics Biotech & Medicals's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Great Novel Therapeutics Biotech & Medicals (ROCO:7427) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Great Novel Therapeutics Biotech & Medicals (ROCO:7427) » Definitions » YoY Rev. per Sh. Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.3, Park Street, Room WR-06, 17th Floor, Nangang District, Taipei, TWN, 11503

Website

http://www.gntbm.com.tw

Great Novel Therapeutics Biotech & Medicals focuses on drug development to treat advanced cancer. The new drugs ranging from epigenetic modulators, a combination of tumor microenvironment-regulating agents, epigenetic immuno-modulators, to the protein degradation drugs targeting HDACs 1, 2, and 3, are in a developing pipeline. These drugs focus on the field of epigenetics, for the demand of clinical unmet needs in advanced and refractory cancers.

Great Novel Therapeutics Biotech & Medicals (ROCO:7427) Headlines

No Headlines